VevaRX review

The reason to read this row is that the pages do not agree with each other on what anything costs. The semaglutide page alone carries four different figures, and two of them are tirzepatide's. Tirzepatide itself is sold only in three-month blocks that auto-renew every three months, with no monthly option on its own page, and the per-month equivalent printed beside the block is wrong by six dollars — the semaglutide page states the correct division for the same number. Three of the peptide products are priced two or three ways each, and in two cases the cart charges a figure the product card never showed. The contradictions run past pricing: the contact page's questions are another product's copy and answer how to take semaglutide with instructions for mixing a powdered drink, and another brand's domain appears in these terms as the site the transactions are conducted on. Coverage is thirty-six states enumerated by name in the questions and all fifty in the terms, twice. No pharmacy, clinician, medical group or compounding class is named anywhere.

Vs median

Not comparable — no per-month rate is published — the verified string carries no monthly figure

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Standard plan, self-directed low dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Varies by dose, plan or tier

Price last updated

September 2026

VevaRX dispenses through a Unspecified — no 503A or 503B claim anywhere facility. No bloodwork is required before you start. A clinician review is included in the price.

VevaRX sells compounded semaglutide and compounded tirzepatide as injections alongside sermorelin, NAD+, glutathione and PT-141, and the reason to read the row is that its own pages do not agree on what any of it costs. The semaglutide page alone carries four figures, two of which are tirzepatide's. Tirzepatide is sold only in three-month blocks that auto-renew every three months, and the per-month equivalent printed beside the block is wrong by six dollars — the semaglutide page states the correct division for the same number. Three peptides are priced two or three different ways each, and in two cases the cart charges the figure that is not on the card. The contradictions extend past pricing: the contact page's questions are another product's copy and answer how to take semaglutide with instructions for mixing a powdered drink, and another brand's domain appears in VevaRX's own terms as the site transactions are conducted on. Coverage is enumerated as thirty-six states in the questions while the terms twice assert all fifty. No pharmacy, clinician, medical group or compounding designation is named.

THE SEMAGLUTIDE PAGE CARRIES FOUR PRICES AND TWO OF THEM BELONG TO TIRZEPATIDE, so what a reader would be charged is not resolvable from the page selling it

• The tirzepatide block advertises an equivalent of $149 a month for a $467 quarterly charge, which is $155.67 — and the semaglutide page states that correct figure for the same plan
• Tirzepatide is sold only in three-month blocks that auto-renew every three months, with no monthly option on its page
• Three peptide products are priced two or three different ways each, and in two cases the cart charges a figure the card does not show
• Another brand's domain appears in these terms as the site the transactions are conducted on
• The contact page's questions are a different product's copy and give dosing instructions for a powdered drink under the question about taking semaglutide
• Coverage is thirty-six named states in the questions and all fifty in the terms, twice
• No pharmacy, clinician, medical group or compounding designation is named, and no milligram is published
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

VevaRX is one of 393 low-dose GLP-1 programs we track, and 254 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What microdosing GLP-1 costs
• Microdosing tirzepatide
• What the evidence actually shows
• The true annual cost of a plan
• What a flat price costs at a low dose